Grants for Independent school districts - Food and Nutrition

This funding opportunity supports Oklahoma-based nonprofit organizations, public entities, tribal nations, and educational institutions in developing infrastructure projects that promote physical activity and nutrition in their communities.

FDA announces the availability of fiscal year (FY) 2024 funds to support one or more projects to 1) collect antimicrobial use data from diverse animal sectors, including domestic livestock, poultry, companion animals (dogs, cats, and horses), and minor species (e.g., fish, sheep, goats) and 2) contribute to the development of data collection frameworks, including providing data and expertise as resources and a public-private partnership frameworks are established. This grant will support the continued advancement of FDA;apos;s initiatives to support antimicrobial stewardship in veterinary settings. It will also support the National Action Plan objectives to engage the animal health community and relevant stakeholders to advance strategies intended to improve understanding of antimicrobial use and foster antimicrobial stewardship in animal agriculture.

This funding opportunity supports researchers in planning high-risk, multi-center clinical studies focused on kidney, digestive, diabetes, and metabolic disorders, helping them develop essential protocols and administrative frameworks before conducting the actual trials.

The Washington State Department of Commerce is offering a grant program to fund retrofitting existing facilities and related projects that aim to achieve energy and operational cost savings. The program is specifically designed to support public entities in Washington State. While the document does not explicitly state the Department of Commerce's broader mission or theory of change, it can be inferred that this grant aligns with a strategic priority to promote energy efficiency, reduce operational costs for public infrastructure, and contribute to environmental sustainability within the state. The program seeks to empower public agencies to invest in critical upgrades that benefit both their operational budgets and the broader community through reduced energy consumption. The primary target beneficiaries of this grant program are public entities within Washington State. This includes local agencies such as cities, towns, counties, special districts, municipal corporations, port districts, and authorities. Additionally, public higher education institutions, K-12 public school districts, state agencies, and federally-recognized tribes located within Washington are eligible to apply. The overarching impact goal is to enhance the energy efficiency of public facilities across the state, leading to long-term operational cost savings and a reduced environmental footprint. By investing in these entities, the program aims to create more sustainable and fiscally responsible public infrastructure. The grant program prioritizes a range of eligible activities focused on improving facility energy efficiency. These include, but are not limited to, HVAC replacement or upgrades, improvements to other mechanical systems, lighting enhancements, insulation upgrades, window replacements, and the purchase and installation of heat pump and geothermal heating systems. The program also supports broader campus or district energy efficiency measures. These priorities directly address the core objective of achieving significant energy and operational cost savings through tangible infrastructure improvements. The focus is on implementing proven technologies and strategies that yield measurable reductions in energy consumption. Expected outcomes of this grant program include a noticeable reduction in energy consumption and associated operational costs for public facilities throughout Washington State. Measurable results would likely include documented energy savings (e.g., kilowatt-hours saved, therms saved), reduced utility expenses, and potentially a decrease in carbon emissions. While specific metrics are not detailed in the provided text, the emphasis on "energy and operational cost savings" suggests a clear intention for quantifiable improvements. The grant's increased cap to $1 million, with a minimum project size of $100,000, indicates a commitment to funding substantial projects that can deliver significant and lasting impacts across the state's public infrastructure.

This funding opportunity provides financial support for researchers developing innovative, non-opioid treatments for various types of pain, with a focus on early-stage studies and collaboration with underrepresented populations.

This program provides funding to public school districts and area career and technical schools for necessary improvements to their facilities.

This grant provides funding to nonprofit organizations, schools, and informal arts and culture groups for public arts and culture events and programs in Georgetown.

The purpose of this research is to systematically evaluate the diastereomeric composition of LEQVIO (Inclisiran), an FDA-approved, N-acetyl galactosamine (GalNAc)-conjugated siRNA drug, and to understand the biological/pharmacological activity of each diastereomer in LEQVIO through stereo chemically controlled synthesis and biological activity assessment using in vitro and animal models. The proposed studies will focus on 1) synthesis of each diastereomer of LEQVIO (Inclisiran) in stereo chemically pure form; 2) assessment of the biological activity of each stereo chemically pure diastereomer in inhibiting PCSK9 activity using in vitro assays and in a transgenic mouse model; 3) development of analytical methods to identify and characterize the stereochemical structure of each diastereomer in LEQVIO; and 4) assessment of the individual contribution of each diastereomer to the overall pharmacological activity of LEQVIO. Tools developed in this research can also be applied to other similar GalNAc-conjugated siRNAs specifically, and other siRNAs in general. Knowledge gained from this research will also contribute to the sameness evaluation of generic siRNAs, and to the quality control of oligonucleotide drugs.

The Avery Community Foundation (ACF) is offering community grants to qualified charitable organizations serving Avery County, North Carolina. This grant program aligns with the foundation's mission to address a broad range of local needs. The ACF seeks to support initiatives that strengthen the community across various sectors, demonstrating a strategic commitment to comprehensive local development. The grant program targets a diverse range of beneficiaries within Avery County, including those in need of human services, education, youth development, health, food/nutrition, and arts. The impact goal is to meet these local needs through funding programs that deliver direct benefits to the community-at-large. The foundation prioritizes organizations that provide programs and services without discrimination based on age, race, national origin, ethnicity, gender, physical ability, sexual orientation, political affiliation, or religious belief. The program focuses on supporting 501(c)(3) public charity nonprofit organizations, organizations with a fiscal agent who is a 501(c)(3) public charity, local governments (including public schools), and fire and rescue departments. Religious entities may also apply for funding to support social outreach and charitable service programs that benefit the community-at-large, but not for general operating support. This focus ensures that funding reaches a wide array of entities capable of implementing effective community programs. While specific measurable results are not explicitly detailed beyond meeting local needs, the foundation expects outcomes that demonstrably improve the quality of life and address the identified challenges within Avery County. The typical grant range of $500 to $1,000 suggests a strategy of providing smaller, impactful grants to support numerous local initiatives. The ACF's theory of change appears to be rooted in empowering local organizations to directly address community needs, thereby fostering a more resilient and thriving local environment.

INTEGRIS Health is offering a grant for programs in specified Oklahoma counties that align with their community health priorities, such as improving access to care, mental health care, obesity prevention, chronic disease management, access to healthy food, and tobacco use prevention, open to 501(c)(3) nonprofits and nonexempt organizations like schools and local government agencies.

This funding opportunity provides financial support for organizations to host conferences and scientific meetings that address important public health issues relevant to the FDA's mission.

This funding opportunity supports predoctoral students in dual-degree programs at institutions without NIH-funded training programs, helping them pursue research and clinical training to become future physician-scientists.

This funding opportunity supports the development of innovative tools and technologies aimed at advancing research and treatment in kidney, urologic, and hematologic diseases, encouraging projects that push scientific boundaries and have broad applications beyond individual research interests.

Summer Meal Program Expansion Grant Applications for the new Summer Meal Program Expansion Grant program are now open through May 7! Program Overview: The Iowa Department of Education has received $900,000 to support the enhancement and expansion of summer meal programs in currently underserved and eligible areas. Program Details: Funding Source: $900,000 from the U.S. Department of Agriculture (USDA) Purpose: Enhance and expand summer meal programs in underserved areas. Target Audience: Iowa children ages 18 and under. Programs Supported: Summer Food Service Program (SFSP) and Seamless Summer Option (SSO). Grant Opportunity: Provides additional revenue source for summer meal programs beyond federal meal reimbursement. Allowable Expenses: Enhancing meal quality, incorporating locally grown foods, updating program equipment, conducting program outreach, and operational/administrative personnel expenses not fully covered through meal reimbursement. Eligible Sites for Expansion: Possible new meal site locations include: Schools Community buildings Libraries Apartment complexes Parks Swimming pools Splash pads Churches Other public sites where children gather Non-Congregate Distribution: Non-congregate distribution may be an option for State agency approved sponsors in rural areas unserved by a congregate meal service. Application Deadline: May 7 Don't miss this opportunity to expand summer meal programs and ensure Iowa children have access to healthy meals during the summer break! Apply now!

This grant provides funding to school districts and educational organizations to help start or expand meal programs that ensure children have access to nutritious breakfasts and summer meals.

The Food and Drug Administration's (FDA), Center for Drug Evaluation and Research (CDER), Office of New Drugs (OND), is announcing this Funding Opportunity Announcement (FOA) for a Cooperative Agreement. The proposed work directly supports the U.S. FDAs stated goal of protecting public health from unacceptable risks from nitrosamine impurities in human drugs. Although significant experimental and policy/regulatory initiatives have been undertaken in this area, there remains a need for further research into and development and refinement of translational and implementable practices that will protect the public against nitrosamine risks while ensuring continued safe access to critical therapeutic drugs. The aim is to improve the safety of human drugs with potential nitrosamine impurity liabilities. In addition to the work outlined above, the award recipient will assess how best to ensure that this research and practices development continues among industry members, non-profits, and/or academic institutions once the FDA funding for this cooperative agreement ends.

The Shullsburg Fund, established in 2004 by area citizens, serves as a permanent funding source dedicated to enhancing the quality of life in and around Shullsburg. Managed as a component of the Community Foundation of Southern Wisconsin, it annually redistributes a portion of its earnings to finance projects and programs that positively impact community life. The fund focuses on supporting non-profit organizations, the local school district, and local government agencies with charitable initiatives. Grants are ceremoniously awarded in June each year, underlining the fund's commitment to community development and welfare. Grant renewed every year. Grant annual deadline: May 15th

The purpose of this Funding Opportunity Announcement (FOA) is to support innovative multidisciplinary and multi-level research designed to develop and/or test interventions to optimize care of persons with Type 2 diabetes from populations with health/health care disparities concordant with evidence-based guidelines. NIH-designated health disparity populations include racial and ethnic minorities (Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asians, Native Hawaiians and other Pacific Islanders), sexual and gender minorities, socioeconomically disadvantaged populations, and underserved rural populations. Proposed projects would be expected to develop and/or test patient-centered strategies, which in addition to optimal glycemic control, would aim at completing other recommended guidelines (e.g., annual eye/foot and urine albumin exam, optimal blood pressure control, intake of ACEIs or ARBs/statin/aspirin and influenza/pneumonia vaccines).

This Notice of Funding Opportunity (NOFO) invites applications from institutions/organizations that propose to establish a Research Resource Center (RRC) for the NIDDK Nutrition Obesity Research Centers (NORC) Program. The NORC Program consists of eleven Centers across the nation that support and enhance the national research effort in nutrition and obesity through cutting-edge basic, clinical, translational, and health disparities research in nutrition science and obesity. In collaboration with the existing NORC program, the RRC will (1) provide administrative support for the entire NORC Program, (2) establish and curate a NORC Program website and centralized repository of research resources , (3) implement a multipronged approach to support and grow the early-to-midcareer research workforce, including individuals from diverse backgrounds, with a goal of maximizing national outreach and impact, (4) administer and manage a NORC Opportunity Program to address gaps and promote collaboration, and (5) manage a Pilot and Feasibility Program.This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn.

This Funding Opportunity Announcement (FOA) invites applications to develop and implement Phase Ib to III clinical trials of promising pharmacological and non-pharmacological interventions that may prevent, delay, or treat the symptoms of Alzheimer's disease (AD) and other age-related dementias using the Alzheimer's disease Clinical Trials Consortium (ACTC) trial coordination and management infrastructure.Research Objectives Utilizing the ACTC, the goal of this FOA is to invite research grant applications that provide clinical testing (Phases Ib-III) of promising pharmacological and/or non-pharmacological interventions for cognitive and neuropsychiatric symptoms in individuals with AD or other aging-related dementias across the spectrum from pre-symptomatic to more severe stages of disease. Working with the ACTC is a cooperative venture between the applicant, the NIA, and the ACTC network. NIA and the ACTC leadership will provide guidance to potential applicants. Potential applicants are strongly encouraged to contact NIA Scientific/Research Contacts (see Agency Contacts, Section VII) and the ACTC study team in order to discuss the feasibility of conducting the proposed trial through the ACTC infrastructure before considering an application. The ACTC infrastructure is welcoming of the following: Academic and industry applicants Pharmacological and non-pharmacological interventions Applications are encouraged that propose the following: Testing candidate therapeutic compounds against novel therapeutic targets Testing repurposed drugs derived from data-driven approaches, including candidates coming from NIA's translational bioinformatics FOA (PAR-17-032) Logistical guidance: Potential applicants undergo initial vetting of proposed study by the ACTC protocol evaluation committee and final review by the steering committee. Applicants should contact the ACTC study team at least 5 months prior to their desired NIA submission cycle. Contact details and more information may be found at actcinfo.org. Applications should anticipate using a centralized IRB. Applicants should be aware of the data and resource sharing requirements. The use of common contract language is strongly encouraged. Note, the ACTC infrastructure is not appropriate for: Single site clinical trials Routine Phase Ia first-in-human Clinical trials funded from this FOA will be implemented through the ACTC. The clinical trials approved for funding will develop their final protocols in conjunction with the ACTC. All ACTC sites will have the option to request participation and will be selected based on their capabilities specific to the individual protocols. Investigators are strongly encouraged to collect blood and other biosamples for future genomic and other 'omic' analyses aimed at interrogating treatment responsiveness and examining predictors of decline and progression. See Section VIII. Other Information for award authorities and regulations.